B.Grimm Pharma Collaborates with Inter Mohosot To Expand Distribution of its Medicines in Cambodia

B.Grimm Pharma, the leading manufacturer and distributor of pharmaceuticals, nutraceuticals, and cosmeceuticals in Thailand, is part of B.Grimm's Healthcare business, one of the three main pillars alongside B.Grimm Power, the listed company, and B.Grimm Industrial businesses. Offering holistic healthcare solutions covering every aspect of the pharmaceutical industry, B.Grimm Pharma has signed a Sole Distribution Agreement with Inter Mohosot Co., Ltd. to enhance access to quality medications in Cambodia. Inter Mohosot will serve as the distribution partner for B.Grimm Pharma's products, covering various therapeutic areas, including Cardiovascular System, Central Nervous System, and Musculoskeletal System. The collaboration will involve over 16 medications addressing common conditions such as depression, epilepsy, hypertension, diabetes, neuropathic pain, and etc.

B.Grimm Pharma Collaborates with Inter Mohosot To Expand Distribution of its Medicines in Cambodia

This partnership aims to provide many patients in Cambodia with fair access to quality treatments, starting in January 2025 at public hospitals, private clinics, and pharmacies in Phnom Penh and surrounding provinces.
Mr. Kittisak Dumrongtananurak, Head of B.Grimm Pharma, stated, "With the growing demand for medications in Cambodia, B.Grimm Pharma is ready to meet the needs for quality pharmaceuticals and healthcare products. We are pleased to partner with Inter Mohosot, a trusted company with deep insights into the pharmaceutical business in Cambodia. This collaboration will not only support our expansion in the Cambodian market but also align with our goal to enhance access to quality medications for a broader population beyond Thailand."
Mr. Borey Koy, CEO of Inter Mohosot Co. Ltd., expressed enthusiasm for the collaboration: "We are excited to partner with B.Grimm Pharma to promote access to quality medications in Cambodia. Inter Mohosot will leverage its expertise and network to complement B.Grimm Pharma's longstanding commitment to product quality, ultimately improving healthcare opportunities for Cambodian citizens."

B.Grimm Pharma and Inter Mohosot aim to ensure widespread availability of quality medications for patients in Cambodia. With the combined strengths of both organizations, they will provide modern healthcare solutions to enhance access to quality treatments effectively and efficiently. With significant growth potential in the Cambodian healthcare market, both companies are well-positioned to meet local demands effectively. Through the shared values of quality and integrity, B.Grimm Pharma and Inter Mohosot aim to improve patient outcomes and drive meaningful change in the healthcare landscape.

This partnership not only signifies a business opportunity but also a shared commitment to genuinely improve the quality of life for people in Cambodia. B.Grimm Pharma is dedicated to developing new innovations while ensuring the best-in-class manufacturing quality standards, ensuring everyone can access essential medications and healthcare products to enhance their quality of life.


ข่าวo:editor+o:healวันนี้

Chula's Breakthrough Arto Sucrose-reduces Tech Cuts Sugar in Fruits by 65% and Converts to Prebiotics for Healthier Eating

Professor Dr. Supaart Sirikantaramas, a lecturer at the Department of Biochemistry, Faculty of Science, and the Center of Excellence in Molecular Crop, Chulalongkorn University, has developed Arto Sucrose-Reduced Technology—a groundbreaking enzyme-based innovation that transforms sucrose in fruits into prebiotics. This technology enables up to a 65% reduction in sugar content while preserving essential nutrients, making high-sugar fruits such as durian, mango, and banana healthier for

เมื่อไม่นานมานี้ ผมได้เจอเคสผู้ป่วยหญิงอา... ประจำเดือนมาเจ็บหน้าอกทุกที สาเหตุโรคลมรั่วในเยื่อหุ้มปอด — เมื่อไม่นานมานี้ ผมได้เจอเคสผู้ป่วยหญิงอายุราว 40 ปี มารักษาด้วยอาการเจ็บแน่นหน้าอก เป็น ๆ หาย...

ฮอนด้า ประกาศแต่งตั้ง "โคจิ อิวานามิ" ดำร... ฮอนด้า ประกาศแต่งตั้ง "โคจิ อิวานามิ" ดำรงตำแหน่งประธานกรรมการบริหารและซีอีโอ — ฮอนด้า ประกาศแต่งตั้ง "โคจิ อิวานามิ" ดำรงตำแหน่งประธานกรรมการบริหารและซีอ...

Iwanami Appointed President & CEO of Hond... Iwanami Appointed President & CEO of Honda Thailand — Iwanami Appointed President & CEO of Honda Thailand, Set to Deepen Emotional Connection and Cust...

BEARHOUSE ฉลอง 6 ปี ปล่อยอัปเดต Patch 3.2... BEARHOUSE ฉลอง 6 ปีแห่งความสุข พร้อมเซอร์ไพรส์พิเศษที่ให้ความสุขแบบไม่มีสิ้นสุด! — BEARHOUSE ฉลอง 6 ปี ปล่อยอัปเดต Patch 3.2 เพิ่มน้ำ +37.5% เพิ่มเนื้อผลไ...

The highly anticipated Heaven747 Songkran... Heaven747 Songkran Festival 2025 Marks the Start of a New Era for New Poipet, Cambodia — The highly anticipated Heaven747 Songkran Festival 2025 made hist...